Top Analysts See 30% Upside for Salesforce (CRM) Ahead of Q1 Earnings

With Salesforce (CRM) set to report its Q1 2026 earnings later today, we’ve collected fresh ratings from Top Analysts, as tracked by TipRanks. These are the best-performing analysts based on accuracy and returns, and most are feeling upbeat about CRM’s prospects.

In total, 17 out of 20 top analysts have reiterated a Buy rating. Their average price target of $359 implies a strong upside of roughly 30% from current levels, signaling confidence in Salesforce’s performance and future growth.

Big Targets, Slight Tweaks, and One Outlier

Leading the bullish crowd is Barclays’ Raimo Lenschow, who maintained a $425 price target, pointing to over 53% upside. He’s joined by Wedbush’s Daniel Ives and RBC’s Rishi Jaluria, both echoing that same target. These analysts believe Salesforce’s big bets on AI, its Data Cloud, and deep enterprise relationships continue to position it for long-term wins.

Goldman Sachs’ (GS) Kash Rangan did trim his target from $400 to $340, but still kept a Buy. That pattern — slightly lower targets but steady optimism — showed up in several notes. Bank of America (BAC), Canaccord, and UBS all made similar moves. The primary concern lies in valuation, but there are no major concerns about the business itself.

Only one analyst issued a Sell: D.A. Davidson’s Gil Luria, who sees CRM dropping to $200, citing broader tech risks. And just two — UBS and Wells Fargo — currently rate the stock a Hold. With so much attention on how Salesforce is navigating macro challenges and monetizing AI, today’s earnings call will be closely watched. Will margins hold up? Are customers still spending? And is generative AI truly paying off?

For now, the top analysts are giving CRM the benefit of the doubt. Whether the company delivers on those expectations — that’s the story we’re about to find out.

Is CRM Stock a Buy?

Despite the bullish sentiment of most top analysts, Salesforce sports a Moderate Buy rating, with an average CRM stock price target of $359.86. This implies a 29.82 upside. Again, this price target is calculated solely on the top analysts’ ratings.

See more CRM analyst ratings